MPS - Oral Health to Dental Medicine Pathway


A unique One-Year program designed to accelerate and enhance your admission into the Dental Medicine Program.

Applications to dental school are at an all time high, thus thousands of applicants must compete for a very limited number of interview spots. The MPS-OH to DM Pathway will not only strengthen your application with a prestigious master’s degree but will also guarantee you an interview spot with CNU College of Dental Medicine.









Why Choose the MPS-to- MD Pathway?


A unique One-Year program designed to accelerate and enhance your admission into medical programs.

A guaranteed interview with the CNU College of Medicine upon achieving MPS GPA of 3.5 and MCAT score of 508. Past student career outcome data showed that: More than 60% of MPS graduates accepted in different medical programs.”


More than 60% of MPS graduates accepted into medical programs.

Why choose MPS?

The Master of Pharmaceutical Sciences (MPS) program will provide you with:

  • Advance your knowledge and skills in drug discovery, regulatory affairs, pharmaceutical analysis and more.

  • Make yourself more competitive in the job market with rewarding careers in research development and regulatory affairs.

  • A greater chance of admission into professional health care programs (MD, PharmD, DO, DDS)

TWO TRACK OPTIONS

    1. 1) ONE-YEAR Capstone Paper (Non-Thesis) Track.


    2. 2) TWO-YEAR Thesis Track.


ONE-YEAR CAPSTONE PAPER (NON-THESIS) TRACK

Get into a ONE YEAR master program with an intensive curriculum and graduate with improved academic profile, significantly higher admission into healthcare professional schools, and a marketable Master’s Degree in the field of Pharmaceutical and Biomedical Sciences.

TWO-YEAR THESIS TRACK

The two-year thesis track is designed to enhance the students’ research skills through hands-on laboratory training in the field of pharmaceutical and biomedical sciences.

Why Choose Us


  • Hear from our students,why they choose this program and what they love about it.

News